TP53 and cancer: Other types of immunotherapies besides ICI and p53 vaccines such as adoptive cell therapy, monoclonal antibodies, oncolytic viruses, and immune system modulators have demonstrated efficacy in various cancer types but have not been tested in combination with p53-reactivating therapies.